Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$8.28M+98.1%-$40.37M-$38M+37.4%-$41.93M+75.8%-$426.08M-445%
$2.2M-57.1%$2.74M-3.7%$2.46M-41.3%$2.66M-24.0%$5.13M+58.4%
$4.46M-51.5%$9.59M-40.2%$10.98M-39.8%$11.9M-30.9%$9.2M-52.9%
-$44.69M-1.4%-$19.07M+37.8%-$18.71M+58.9%-$29.38M+45.9%-$44.06M+41.8%
$3.04M+119%$861K-46.8%$0$550K-62.8%$1.39M-64.2%
$35.86M-20.7%$26.03M-55.3%$18.9M-18.0%$25.28M-67.1%$45.23M+233%
$1.44M-26.6%$1.47M+80.9%$1.96M-70.1%
-$7.4M-336%$6.96M+131%$1.66M+108%-$4.09M$3.14M+103%
-$47.73M-5.0%-$19.93M+38.2%-$18.62M+58.3%-$29.93M+46.3%-$45.45M+42.9%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pacific Biosciences of California generate?
Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
What is Pacific Biosciences of California's free cash flow?
After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
Where does Pacific Biosciences of California's cash flow data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.